Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes
Nicolas Skuli, … , Brian Keith, M. Celeste Simon
Nicolas Skuli, … , Brian Keith, M. Celeste Simon
Published March 19, 2012
Citation Information: J Clin Invest. 2012;122(4):1427-1443. https://doi.org/10.1172/JCI57322.
View: Text | PDF | Corrigendum
Research Article Vascular biology

Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes

  • Text
  • PDF
Abstract

Localized tissue hypoxia is a consequence of vascular compromise or rapid cellular proliferation and is a potent inducer of compensatory angiogenesis. The oxygen-responsive transcriptional regulator hypoxia-inducible factor 2α (HIF-2α) is highly expressed in vascular ECs and, along with HIF-1α, activates expression of target genes whose products modulate vascular functions and angiogenesis. However, the mechanisms by which HIF-2α regulates EC function and tissue perfusion under physiological and pathological conditions are poorly understood. Using mice in which Hif2a was specifically deleted in ECs, we demonstrate here that HIF-2α expression is required for angiogenic responses during hindlimb ischemia and for the growth of autochthonous skin tumors. EC-specific Hif2a deletion resulted in increased vessel formation in both models; however, these vessels failed to undergo proper arteriogenesis, resulting in poor perfusion. Analysis of cultured HIF-2α–deficient ECs revealed cell-autonomous increases in migration, invasion, and morphogenetic activity, which correlated with HIF-2α–dependent expression of specific angiogenic factors, including delta-like ligand 4 (Dll4), a Notch ligand, and angiopoietin 2. By stimulating Dll4 signaling in cultured ECs or restoring Dll4 expression in ischemic muscle tissue, we rescued most of the HIF-2α–dependent EC phenotypes in vitro and in vivo, emphasizing the critical role of Dll4/Notch signaling as a downstream target of HIF-2α in ECs. These results indicate that HIF-1α and HIF-2α fulfill complementary, but largely nonoverlapping, essential functions in pathophysiological angiogenesis.

Authors

Nicolas Skuli, Amar J. Majmundar, Bryan L. Krock, Rickson C. Mesquita, Lijoy K. Mathew, Zachary L. Quinn, Anja Runge, Liping Liu, Meeri N. Kim, Jiaming Liang, Steven Schenkel, Arjun G. Yodh, Brian Keith, M. Celeste Simon

×

Figure 5

Endothelial HIF-2α deficiency impairs hypoxic induction of angiogenic genes.

Options: View larger image (or click on image) Download as PowerPoint
Endothelial HIF-2α deficiency impairs hypoxic induction of angiogenic ge...
(A and B) Hypoxic induction of HIF and Dll4/Notch pathway target gene expression was assessed by qRT-PCR in control, HIF-2α (A), and HIF-1α (B) KO lung ECs. The relative ratio of hypoxic to normoxic gene expression (fold hypoxic induction) is shown for control and KO ECs (n = 6). Note that Hes1 charts for HIF-2α KO ECs were separated for the 2 replicates. (C) Dll4 staining in adductor muscle for ligated and nonligated limb in control and KO mice at day 7 after surgery. (D) Quantification of fluorescence intensity revealed decreased Dll4 expression in the ligated limb of KO mice after ligation. (E) Levels of Ang2 were assessed in control (n = 8) and KO (n = 9) serum after ligation. (F) Ang2 staining in adductor muscle for ligated and nonligated limb in control and KO mice at day 7 after surgery. Arrowheads denote collaterals. (G) Quantification of fluorescence intensity revealed decreased Ang2 expression in the ligated limb of KO mice. (H) Dll4-immunofluorostained sections of skin tumors from control and KO mice after 25 weeks of DMBA/TPA treatment. (I) Quantification of fluorescence intensity revealed decreased Dll4 expression in skin tumors of KO mice (n = 10 [control]; 11 [KO]). Scale bars: 40 μm (C and H); 20 μm (F). Original magnification, ×200. *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts